OWC Pharmaceutical Research Corp’s (OTCQB: OWCP) wholly owned subsidiary of One World Cannabis Ltd., an Israeli research and development company focused on cannabis-based products and treatments, announced that it would be a senior presenter at the “Medical Cannabis and Cannabinoids” Conference organized by the Czech Republic Ministry on March 4-7, 2015.
It’s only a matter of time until marijuana will be legal everywhere. Colorado and Washington are clearly only the beginning. For now medical marijuana which is getting legalized around the world and several Israeli forms have already placed themselves at the forefront of cannabis research.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.
The Medical Cannabis and Cannabinoids conference is designed to assist Czech health care professionals, including doctors, nurses and other medical staff, better understand medical cannabis and cannabinoids.
Dr. Yehuda Baruch, One World Cannabis Director of Research and Regulatory Affairs, will host four sessions discussing the human endocannabinoid system and the effects of various strains of medical cannabis in the treatment of medical symptoms, as well as dosing concerns like how to start, how long, how and when to stop.
Dr. Tomáš Zábranský, an advisor on drug policy to the Czech Prime Minister and one of the Conference organizers: “Yehuda [Dr. Baruch] is the father and mother of the Czech Republic education programs on medical cannabis for the medical staff. This is the kick-off and he [Dr. Baruch] was extremely helpful in all the preparations of the Conference.”
The Company’s Research Division, headed by Dr. Baruch, will be focused on developing and conducting studies designed to produce new cannabis-based products for the treatment of various diseases and conditions. In addition to the R&D work, the Company’s Consulting Division provides expert assistance to government officials and regulatory agencies in establishing the infrastructure necessary for the safe care and management of patents using medical cannabis.
Ziv Turner, CEO at One World Cannabis, commented, “I firmly believe that Dr. Baruch’s unique experience will further establish One World Cannabis as a leading organization in the medical-cannabis field – both in research and development and in regulatory consultant services to international entities.”
One World Cannabis Ltd. was founded in 2014 by a group of professionals with expertise in the field of medical cannabis (marijuana) treatment and medical cannabis regulatory affairs. The Company’s Research Division is focused on pursuing clinical trials evaluating the effectiveness of cannabinoids in the treatment of various medical conditions.
